SEP 10, 2026 · PHASE 1 TRIAL
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
ClinicalTrials.gov
Phase 1 interventional trial in recruitment examining a novel agent (cagrilintide) on a surrogate bone metabolism endpoint; no results reported in this registry record.
Reported
Planned enrollment144
Study phasePhase 1
Primary outcome measureRelative change in volumetric bone mineral…